FRIEL ROBERT F 4

What Happened
Robert Friel, a director of Xylem Inc. (XYL), received an award of 2,481 restricted stock units (RSUs) on 2026-05-14. The RSUs are recorded at $116.88 per share for a total grant value of $289,979. This transaction is an award/grant (code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-14; Form 4 filed 2026-05-15 (appears timely).
• Grant price used for reporting: $116.88 per share; total reported value $289,979.
• Award type: Restricted stock units under the Xylem 2011 Omnibus Incentive Plan (Amended Feb 24, 2016).
• Vesting/settlement: RSUs scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders (Footnote F1). The reporting person has elected to defer settlement of the RSU award until separation from service.
• Dividend treatment: Shares include additional amounts due to dividend reinvestment (Footnote F2).
• Shares owned after transaction: Not specified in the filing.
• Transaction code: A = Award/Grant. No indication of late filing (no "L" code).

Context
RSUs are a form of compensation that convert to shares (or cash) upon vesting; they do not reflect an immediate purchase or sale and should be viewed as part of director pay rather than a direct market sentiment signal. The deferral election means actual share delivery is postponed until the director leaves service.